drugset / Trial / NCT05836506
A Study to Assess the Relative Bioavailability of Immediate Release Formulations of ABBV-903 in Healthy Adult Participants
RandomizedSequentialOpen-labelTreatment
Summary
The main objective of this study is to assess the relative bioavailability and pharmacokinetics of ABBV-903 in healthy adult participants.
Timeline
- Start
- 2023-04-18
- Primary completion
- 2023-06-20
- Completion
- 2023-06-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABBV-903 | Unknown | — | Oral |
Indications
No indication recorded.